SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form POS AM - Post-Effective amendments for registration statement:
SEC Accession No. 0001193125-15-345705
Filing Date
2015-10-16
Accepted
2015-10-16 16:19:09
Documents
3

Document Format Files

Seq Description Document Type Size
1 POST-EFFECTIVE AMENDMENT NO.1 TO FORM S-1 d25613dposam.htm POS AM 160743
2 EX-23.1 d25613dex231.htm EX-23.1 2302
3 GRAPHIC g25613cov_bc.jpg GRAPHIC 7182
  Complete submission text file 0001193125-15-345705.txt   174160
Mailing Address 11080 CIRCLEPOINT ROAD SUITE 140 WESTMINSTER CO 80020
Business Address 11080 CIRCLEPOINT ROAD SUITE 140 WESTMINSTER CO 80020 720-940-2200
ARCA biopharma, Inc. (Filer) CIK: 0000907654 (see all company filings)

IRS No.: 363855489 | State of Incorp.: DE | Fiscal Year End: 1231
Type: POS AM | Act: 33 | File No.: 333-187508 | Film No.: 151162248
SIC: 2835 In Vitro & In Vivo Diagnostic Substances